Indeed, the expression of hepatic CYP7B1 was found to be diminished in animal models of diabetes and NAFLD, implicating the alternative pathways may contribute to human metabolic homeostasis [67,68]. The gene discussed is CYP7B1; the disease is metabolic dysfunction-associated steatotic liver disease.